PAPP-A, ProMBP, and PAPP-A/ProMBP ratio are related to the extent of angiographic coronary artery disease in stable angina patients  by Cosin-Sales, Juan et al.
ABSTRACTS - Myocardial Ischemia and Infarction 359A 
1098-91 The Additional Value of C-Reactive Protein in Patients 
With Intermediate Coronary Lesions and a Normal 
Fractional Flow Reserve 
Marliin Mew&en, Robbert J. De Winter, Steven A. Chamuleau. Karel T. Koch, Jan P. 
van Straalen, M. Bax, Carl E. Schotborgh. Gerard T. Sanders, Jan G. Tijssen, Jan J. 
Piek. Academic Medical Center, Amsterdam, The Netherlands 
Background: Five to ten percent of patients still experience major adverse cardiac 
events (MACE) after deferral of PTCA based on a normal fractional flow reserve (FFR 
zQ.75). This study was conducted to investigate the prognostic value of plasma C-reac- 
tive protein (CRP) in patients in whom PTCA was deferred based on a nomxxl FFR. 
Methods: Plasma levels of CRP were measured in 71 patients with stable angina under- 
going cardiac catheterization for an intermediate coronary lesion with a mean diameter 
stenosis of 52%. Maximum hyperemia was induced by 20-40 pg IC adenosine to deter- 
mine FFR, defined as the ratio of mean distal coronary pressure to mean aorlic pressure 
during maximum hyperemn. Patients were followed for one-year for documentation of 
MACE related to the intermediate leston. Receiver-operating-characteristic-curve analy- 
sis was used to evaluate the prognostic performance of CRP and to determine the best- 
cut-off-value (BCV). 
Results: During follow up six (8%) MACE (I CABG and 5 PTCAs) occurred. The BCV for 
CRP was determined at 5.0 mg/l. All patients, except one. in whom MACE occurred, had 
a CRP b5.0 mgll (Figure). CRP was significantly higher in the group with compared to the 
group without MACE (median; 5.5 mg/l, range; 4.7-42.4 vs. 2.1 mg/l, range; 0.20-16.9, 
~0.0001). 
Conclusion: A low CRP is strongly associated wth an uncompkcated follow up in 
patients with hemodynamic non-significant coronary lesions. Plasma levels of CRP are 
relevant for risk stratification in intermediate coronary lesions. 
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1098-89 The Neurohumoral Response to Exercise in Coronary 
Heart Disease and the Relationship With Inducible 
lschemia 
Caroline A. Daly, Michael Henein, Wright Christine, Leong Ng. Kim Fox, Royal Brompton 
Hospital, London, United Kingdom 
Background Neurohumoral substances, in particular BNP, are increasingly recognised 
as important prognostic indicators I” a wide spectrum of conditions involving heart fail- 
ure. Neurohumoral testing is proposed as a potenbal adjunct to investigation of patients 
with coronary disease. Our aim was to investigate the response of ANP, BNP, NT BNP 
and cardiotrophin (CT-l) to stress and define the response in relation to ischaemia and 
inducible ventricular dysfunction in patients with angina. Methods 70 patients with stable 
angina and presewed ventricular function (angina group), and 32 healthy volunteers 
(controls) participated. All subjects had resting echocardiography to exclude systolic dys- 
function or other slgnlficant pathology. 49 of the angina group also had stress echocar- 
diography to determine the extent and severity of inducible ischaemia. Baseline bloods 
for ANP, BNP, NT BNP and cardiotrophin were taken under standardised conditions after 
30 minutes resting. Subjects then undenvent symptom limited exercise testing ( Bruce 
protocol) with bloods drawn at peak exercise and again at 15 and 30 minutes post exer- 
ase. Stress echocardiography was performed in the conventional manner with dob- 
&mine infusion increasing in increments, and the addition of atropine if necessary, to 
achieve target heart rate. Results Baseline BNP and NT-BNP were significantly higher in 
patients with angina vs controls. ANP and BNP, but not NT-BNP or CT, rose on exercise, 
with rapid return to baseline levels, in both the angina group and the controls. This rise 
was exaggerated in BNP in the angina group. ABNP was significantly greater in the 
angina group vs controls. Quantification of the increase in BNP did not correlate with 
other indices of inducible ischaemia. Conclusions BNP and NT-BNP are elevated in 
angina with preserved ventricular function. BNP increases in an exaggerated manner 
during exercise stress in patients with angina. These findings warrant further investiga- 
tion to determine the cause, and clinical implications of BNP release during exercise 
stress. 
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1098-90 Proinflammatory Cytokines and Neutrophil Activation in 
Stable Angina 
Johnnv Niim, Anders Wikby, Lena Jonasson, Research Center of Cardiovascular and 
Metabolic Diseases, Hagland Hospital, Eksj& Sweden, University Hospital, LtnkBping, 
Sweden 
Background: There is evidence for a chronic immune activation in coronary artery dis- 
ease (CAD), but the nature of this immune response is not fully defined. We examined 
the cytokine profile in patients with stable angina (SA) and related it to lymphocyte recep- 
tor expression and neutrophll activation. Methods: 45 men (< 60 years old) with SA and 
anglographically verified CAD were included as well as 45 healthy controls. Interleu- 
kin(lL)-6, IL-IO, IL-4 receptor(R), IL-I receptor antagonist and C-reactive protein 
(CRP) were measured in serum. Three colour flow cytomeby was performed on whole 
blood or purified neutrophils using monoclonal antIbodies against CD3, CD4, CD8, 
CD19. CD1 1 b, CD4la, CD62L, CD89, CD45, CD56, CD16. Results: Patients had higher 
levels of CRP, IL-6, IL-I Ra and IL-4R (see Table) and an increased IL-6/IL-4R ratio com- 
pared with controls (0,07 vs 0,04, p<O,OOl). They also had increased numbers of neutro- 
Phil-platelet complexes (CD4la+CDll b+CD45+). CRP (r = 0,6. p < 0,001) as well as IL- 
6, IL-1 Ra and IL-4R were related to neutrophil-platelet complexes in patients but not in 
controls. CRP and cyiokines were not related to lymphocyte receptor expression. Con- 
clusion: Raised levels of CRP and a proinflammatory cytokme profile in SA patients 
were strongly associated with neutrophil activation, assessed by increased neutrophil- 
platelet adhesion. Our data indicate that neutrophil-platelet interaction is a dominant fac- 
tor in the systemic inflammatory state of stable CAD. 
CRP ms/l 
IL-6 pg/ml 
IL-1 Ra p@ml 
IL-4R pg/ml 
IL-IO pg/ml 
CD4la+CDll b+CD45+ cells/mm3 
Patients Controls p< 
4,1+5,8 1,3*1,1 0.01 
4.li3.8 1,8*0,9 0,001 
501+207 363*193 0,Ol 
55,6+13 48.2*9,5 0,Ol 
2,8*2.5 2,1*2.1 NS 
541+334 376*174 0.01 
1098-114 PAPP-A, ProMBP, and PAPP-AlProMBP Ratio Are 
Related to the Extent of Angiographic Coronary Artery 
Disease in Stable Angina Patients 
Juan Cosin-Sales Paul Kaminski, Michael Christiansen, Claus Oxvig, Michael T. 
Overgaard, David Holt, Juan Carlos Kaski, St. George’s Hospital Medical School, 
London, United Kingdom, Statens Serum Institut, Copenhagen, Denmark 
Background: Pregnancy associated plasma protein A (PAPP-A) is a metalloproteinase 
that has been related to the culprit plaque in unstable syndromes. PAPP-A liberates insu- 
lin like growth factor (IGF) from Its binding protein and promotes IGF local effects. 
ProMBP (PAPP-A endcgenous inhibitor) inhibits this effect. We studled the relationship 
among PAPP-A, ProMBP and PAPPAJProMBP ratio and coronary disease extent in sta- 
ble angina patients. 
Methods: We studied 94 male patients (62210 years old) with stable angIna who under- 
went diagnostic coronary angiography. Patients were divided into 3 groups: Group 0 (no 
coronary artery stenosis > 50%); I (single vessel disease) and II (multivessel disease). 
Levels of PAPP-A and Pro-MBP were measured with an ELISA assay employing mono- 
clonal antibodies. 
Results There were no significant differences between groups regarding traditional risk 
factors and medical treatments. Patients in group II were significantly older. PAPP-A lev- 
els and PAPP-AIProMBP ratio were significantly higher and ProMBP levels significantly 
lower, III patients with greater coronary disease extent (table). After adjustment for risk 
factors, medications and age (multivariate linear regression) ProMBP and the ratio 
PAPP-AfProMBP remained significant, although PAPP-A level was affected by the age. 
Conclusion: PAPP-A/ProMBP ratio increases with the extent of disease, suppotting the 
role of IGF in coronary disease and defines a better marker for coronary disease extent 
than PAPP-A itself. 
Oneway-ANOVA Group 0 (n=25) Group I (n=26) Group II (n=43) P value 
Age 58.4ilO.3 58.7+11.2 66.328.7 0.001 
PAPP-A (mlU/L) 5.1 +I .4 5.021 .o 6.0+1.9 0.017 
Pro-MBP (mlU/L) 1892.8+391.0 1544.a474.5 1585.72647.9 0.042 
PAPPNProMBP 2.8fl.6 x 10-s 3.5+1.0x IO” 4.2il.5 x 10.~ <O.mt 
